Independent fund research. Built on SEC filings.

How we research funds

ETF overlap

TMED vs QAAGZX overlap: 46% of top holdings shared

Bottom line

How much do TMED and QAAGZX overlap?

46% of their top holdings overlap by weight. 7 securities appear in both funds' top 25, making up 39.4% of TMED's assets and 30.4% of QAAGZX's. They share a meaningful core but differ in the rest of the portfolio.

QAAGZX holds far more positions (277 vs 102), so it is broader beyond the top names.

Updated Nov 22, 2026

Overlap at a glance

TMEDQAAGZX
Weight overlap (top 25)46%
Shared holdings7
Weight in shared holdings39.4%30.4%
Total positions102277
Expense ratio0.44%0.86%
Holdings as ofJun 30, 2026Jun 30, 2026

Source: SEC Form N-PORT (periods Jun 30, 2026 / Jun 30, 2026)

Holdings TMED and QAAGZX have in common

Holding% of TMED% of QAAGZXOverlap
Eli Lilly & Co16.71%14.06%14.06%
Unitedhealth Group Inc6.52%5.88%5.88%
Gilead Sciences Inc4.44%2.79%2.79%
Thermo Fisher Scientific Inc4.11%2.53%2.53%
Danaher Corp2.96%1.44%1.44%
Intuitive Surgical Inc2.43%1.89%1.89%
Stryker Corp2.22%1.78%1.78%

Source: SEC Form N-PORT (periods Jun 30, 2026 / Jun 30, 2026)

Free weekly newsletter

The Fund Letter

Get fee cuts and hikes, fund closures and mergers, and one plain-English idea to make your portfolio cheaper — every week.

Free. Unsubscribe anytime. We never sell your email.

What each fund holds that the other doesn't

Top-25 holdings that appear in only one of the two funds' top 25.

Only in TMED

  1. Cencora Inc — 2.75%
  2. Agilent Technologies Inc — 2.61%
  3. Alnylam Pharmaceuticals Inc — 2.60%
  4. Insulet Corp — 2.38%
  5. Dyne Therapeutics Inc — 2.03%
  6. Elanco Animal Health Inc — 1.91%
  7. Pfizer Inc — 1.91%
  8. Cytokinetics Inc — 1.69%
  9. Waters Corp — 1.68%
  10. West Pharmaceutical Services — 1.65%
  11. Ascendis Pharma A/s — 1.60%
  12. Biogen Inc — 1.55%
  13. Mckesson Corp — 1.46%
  14. Dexcom Inc — 1.46%
  15. Immunome Inc — 1.38%

Only in QAAGZX

  1. Johnson & Johnson — 6.64%
  2. Abbvie Inc — 5.12%
  3. Merck & Co. Inc. — 4.00%
  4. Vertex Pharmaceuticals Inc — 2.26%
  5. Bristol-myers Squibb Co — 2.12%
  6. Abbott Laboratories — 1.91%
  7. Amgen Inc — 1.80%
  8. Elevance Health Inc — 1.54%
  9. Natera Inc — 1.44%
  10. Guardant Health Inc — 1.22%
  11. Cardinal Health Inc — 1.04%
  12. Royalty Pharma Plc- Cl A — 0.97%
  13. Tenet Healthcare Corp — 0.94%
  14. Cvs Health Corp — 0.93%
  15. Kymera Therapeutics Inc — 0.89%

Asset mix

Asset typeTMEDQAAGZX
Stocks99.3%96.9%
Preferred stock—2.2%
Cash & short-term funds0.7%0.9%
Bonds—0.1%

Source: SEC Form N-PORT (periods Jun 30, 2026 / Jun 30, 2026)

Country mix

CountryTMEDQAAGZX
US93.3%92.3%
GB—1.8%
DK1.6%0.7%
DE1.6%—
KY1.1%0.5%
NL0.9%1.0%
IE—0.8%
BM—0.7%

Source: SEC Form N-PORT (periods Jun 30, 2026 / Jun 30, 2026)

Check another pair

FAQ

How much do TMED and QAAGZX overlap?
About 46% by weight. 7 securities appear in both funds' top 25 holdings; they make up 39.4% of TMED's assets and 30.4% of QAAGZX's. They share a meaningful core but differ in the rest of the portfolio.
What stocks do TMED and QAAGZX have in common?
The largest shared holdings are Eli Lilly & Co, Unitedhealth Group Inc, Gilead Sciences Inc, Thermo Fisher Scientific Inc, Intuitive Surgical Inc.
Should I own both TMED and QAAGZX?
They overlap in part. Owning both concentrates you in the shared names; check that the combined weight in those stocks is what you intend.
Which holds more stocks, TMED or QAAGZX?
QAAGZX is broader, with 277 positions versus 102 for TMED. Overlap here is measured on each fund's top 25 holdings, which carry most of the weight.

Overlap is computed from each fund's top 25 holdings in its latest SEC Form N-PORT filing, with weights normalized to the top 25; for each shared security we count the smaller of the two weights. Educational information, not investment advice.